Tumors Metastatic to Brain
16
1
2
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
2 terminated out of 16 trials
83.3%
-3.2% vs benchmark
6%
1 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
Quantitative MRI in Assessing Disease in Patients With Brain Tumors
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma